Form 4: Galecto Director Carl Goldfischer Granted Stock Options Under Compensation Policy

Galecto, Inc. Director Carl Goldfischer was granted 1,440 stock options with an exercise price of $3.22, vesting over one year, as part of the company's non-employee director compensation policy.

Summary

• Carl Goldfischer, a Director of Galecto, Inc. (GLTO), was granted 1,440 stock options.
• The stock options have an exercise price of $3.22 per share.
• The grant occurred on June 18, 2025, which was the date of Galecto's 2025 Annual Meeting of Stockholders.
• This grant was made in accordance with the Issuer's Non-Employee Director Compensation Policy.
• The shares underlying the option will vest in equal monthly installments until June 18, 2026, which is the first anniversary of the grant date.
• The stock options are set to expire on June 18, 2035.

Sentiment

Score: 7

Explanation: The filing reports a routine compensation event for a director, which is generally viewed as a positive for corporate governance and alignment of interests, without indicating any negative operational or financial news.

Positives

• The grant of stock options to Director Carl Goldfischer aligns his interests with those of shareholders, incentivizing long-term company performance.
• The transaction demonstrates the consistent application of Galecto's established Non-Employee Director Compensation Policy, indicating structured corporate governance.

Future Outlook

This filing details the future vesting schedule of 1,440 stock options granted to Director Carl Goldfischer, which will vest in equal monthly installments until June 18, 2026.

Industry Context

The grant of stock options to non-employee directors is a common and standard practice in the biotechnology industry and among publicly traded companies, serving to align director incentives with long-term shareholder value creation and retention.

Corporate Governance

Related Party Transactions

• The grant of stock options to Carl Goldfischer, a Director of Galecto, Inc., constitutes a related party transaction, executed under the company's established Non-Employee Director Compensation Policy.

Stakeholder Impact

• Shareholders: The grant of stock options aligns the director's financial interests with long-term shareholder value, potentially leading to more focused decision-making aimed at increasing stock price.

Next Steps

• The granted stock options will continue to vest in equal monthly installments until June 18, 2026.

Key Dates

Recommendation

Keywords

Galecto, GLTO, Stock Option, Director Compensation, SEC Form 4, Carl Goldfischer, Equity Grant, Insider Transaction